Skip to main content

Table 4 Sensitivity analysis for each variable considering an identical ACUR for each intervention group

From: Ablation by three-dimensional electroanatomical mapping versus anti-arrhythmic drug therapy: a cost-utility analysis in the treatment of idiopathic ventricular arrhythmias

Variables

Baseline Cost

Cost variation

Temporal Horizon to 4 years

Cost variation

Temporal Horizon according to life expectancy

3D Ablation (USD)

6,047.94

1,576.98

19,112.71

Drugs

0%

1832%

-577%

Transfer from province

0%

806%

-187%

Cardiological studies

0%

781%

-217%

External consultation (USD)

16.49

347.03

-180.18

  1. ACUR: Average Cost-Utility Ratio
  2. USD: United State Dollars